NCT02902679 A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment Status COMPLETED Phase PHASE1
NCT02872649 Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD) Status TERMINATED Phase PHASE2
NCT02846532 Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure Status COMPLETED Phase PHASE3
NCT02833948 Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) Status COMPLETED Phase PHASE3
NCT02807909 A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02805335 Comparison Between Sutureless Devices for PICC and a New System KT FIX PLUS Status UNKNOWN Phase NA
NCT02671461 Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" Status COMPLETED Phase PHASE2
NCT02639143 Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients Status COMPLETED Phase PHASE4
NCT02629497 Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus Status COMPLETED Phase EARLY_PHASE1
NCT02608970 Safety and Tolerability Study of BMS-986177 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02497716 Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children Status COMPLETED Phase PHASE1
NCT02486367 Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR) Status COMPLETED Phase PHASE4
NCT02459613 Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis Status TERMINATED Phase PHASE1/PHASE2